CIK 0001750149
- Non-accelerated filer
- Smaller reporting company
Inhibikase Therapeutics, Inc.
Sign in to watch- Ticker
- IKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263407249
- Phone
- +1 302-295-3800
- Business address
- 1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 5,000 shares at $0.98 ($4,880)
- 4 Open-market buy President and CEO bought 10,000 shares at $0.60 ($6,000)
- 4 Open-market buy Chief Financial Officer bought 3,948 shares at $0.64 ($2,543)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion President and CEO acquired 21,853 shares (option exercise)
- 4 Open-market buy President and CEO bought 23,589 shares at an average $1.97 ($46,558)
- 4 Exercise or conversion President and CEO acquired 21,853 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 16,918 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
Page 5 of 6 · 112 filings